The insulin-like growth factor axis in cell cycle progression - PubMed (original) (raw)
Review
. 2003 Nov-Dec;35(11-12):740-50.
doi: 10.1055/s-2004-814162.
Affiliations
- PMID: 14710353
- DOI: 10.1055/s-2004-814162
Review
The insulin-like growth factor axis in cell cycle progression
J Dupont et al. Horm Metab Res. 2003 Nov-Dec.
Abstract
Emerging evidence suggests that members of the Insulin-like Growth Factors (IGFs) family, including IGF-I, IGF-II, the IGF-I receptor (IGF-IR), and the IGF-binding proteins (IGFBPs) play a central role in the development and progression of cancer. Cancer cells exhibit an increased and deregulated proliferative activity. Abnormalities in many positive and negative modulators of the cell cycle are also frequent in many cancer types. Recent advances in the understanding of cell-cycle control mechanisms have been applied to outline the molecular mechanism through which IGFs regulate cell cycle progression. In this review, we will provide a brief overview of the role of the IGF system as a regulator of some components of the cell cycle.
Similar articles
- Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?
Meinbach DS, Lokeshwar BL. Meinbach DS, et al. Urol Oncol. 2006 Jul-Aug;24(4):294-306. doi: 10.1016/j.urolonc.2005.12.004. Urol Oncol. 2006. PMID: 16818181 Review. - An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A. Alexia C, et al. Biochem Pharmacol. 2004 Sep 15;68(6):1003-15. doi: 10.1016/j.bcp.2004.05.029. Biochem Pharmacol. 2004. PMID: 15313394 Review. - Insulin-like growth factors and cancer.
Yu H, Berkel H. Yu H, et al. J La State Med Soc. 1999 Apr;151(4):218-23. J La State Med Soc. 1999. PMID: 10234899 Review. - The role of the IGF axis in hepatocarcinogenesis.
Scharf JG, Braulke T. Scharf JG, et al. Horm Metab Res. 2003 Nov-Dec;35(11-12):685-93. doi: 10.1055/s-2004-814151. Horm Metab Res. 2003. PMID: 14710347 Review. - Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B. Viereck V, et al. J Cell Biochem. 2007 Sep 1;102(1):28-40. doi: 10.1002/jcb.21274. J Cell Biochem. 2007. PMID: 17372931
Cited by
- Insulin-like growth factors and aging: lessons from Laron syndrome.
Werner H, Laron Z. Werner H, et al. Front Endocrinol (Lausanne). 2023 Oct 24;14:1291812. doi: 10.3389/fendo.2023.1291812. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37941907 Free PMC article. Review. - Effects of gonadotropins, 11-ketotestosterone, and insulin-like growth factor-1 on target gene expression and growth of previtellogenic oocytes from shortfinned eels, Anguilla australis, in vitro.
Nguyen AT, Damsteegt EL, Chia JHZ, Kazeto Y, Lokman PM. Nguyen AT, et al. Fish Physiol Biochem. 2022 Aug;48(4):853-867. doi: 10.1007/s10695-022-01090-4. Epub 2022 Jun 2. Fish Physiol Biochem. 2022. PMID: 35652992 - BRCA1: An Endocrine and Metabolic Regulator.
Werner H. Werner H. Front Endocrinol (Lausanne). 2022 Mar 31;13:844575. doi: 10.3389/fendo.2022.844575. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432218 Free PMC article. Review. - The Management of Symptomatic Lumbar Disc Herniation in Pregnancy: A Systematic Review.
Whiles E, Shafafy R, Valsamis EM, Horton C, Morassi GL, Stokes O, Elsayed S. Whiles E, et al. Global Spine J. 2020 Oct;10(7):908-918. doi: 10.1177/2192568219886264. Epub 2019 Dec 26. Global Spine J. 2020. PMID: 32905728 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources